Amsterdam Molecular Therapeutics

Showing 2 posts of 2 posts found.

Verdict on AMT’s gene therapy expected soon

May 11, 2011
Research and Development, Sales and Marketing AMT, Amsterdam Molecular Therapeutics, gene therapy, genes

Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …

Professor Sander van Deventer appointed to AMT supervisory board

May 10, 2010
Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development

Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …

The Gateway to Local Adoption Series

Latest content